MAISEE SAYAOVANG: Open Payments
NPI 1881003861 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 27 payments from 13 companies in 2025. Trend: 2023 $750 · 2024 $903 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $159 |
| ABBVIE INC. | 4 | $80 |
| Exact Sciences Corporation | 2 | $58 |
| Novo Nordisk Inc | 3 | $52 |
| Lilly USA, LLC | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Cranial Technologies, Inc | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: AIRSUPRA, VRAYLAR, The Cologuard Plus Collection Kit, Ozempic, MOUNJARO, FANAPT, Doc Band, CAPLYTA.
Industry payments across WI — which companies pay providers there.
